Lassa Fever Virus Peptides Predicted by Computational Analysis Induce Epitope-Specific Cytotoxic-T-Lymphocyte Responses in HLA-A2.1 Transgenic Mice
Open Access
- 1 October 2005
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 12 (10), 1223-1230
- https://doi.org/10.1128/cdli.12.10.1223-1230.2005
Abstract
Lassa fever is a hemorrhagic disease caused by Lassa fever virus (LV). Although the precise host defense mechanism(s) that affords protection against LV is not completely understood, cellular immunity mediated by cytotoxic T lymphocytes (CTLs) plays a pivotal role in controlling viral replication and LV infection. To date, there have been no reports mapping major histocompatibility complex (MHC) class I-binding CTL epitopes for LV. Using computer-assisted algorithms, we identified five HLA-A2.1-binding peptides of LV glycoprotein (GP) and two peptides from LV nucleoprotein (NP). Synthesized peptides were examined for their ability to bind to MHC class I molecules using a flow cytometric assay that measures peptide stabilization of class I. Three of the LV-GP peptides tested (LLGTFTWTL, SLYKGVYEL, and YLISIFLHL) stabilized HLA-A2. The LV-NP peptides tested failed to stabilize this HLA-A2. We then investigated the ability of the HLA-A2-binding LV-GP peptides to generate peptide-specific CTLs in HLA-A2.1 transgenic mice. Functional assays used to confirm CTL activation included gamma interferon enzyme-linked immunospot (ELISPOT) assays and intracellular cytokine staining of CD8+T cells from peptide-primed mice. CTL assays were also performed to verify the cytolytic activity of peptide-pulsed target cells. Each of the LV-GP peptides induced CTL responses in HLA-A2-transgenic mice. MHC class I tetramers prepared using one LV-GP peptide that showed the highest cytolytic index (LLGTFTWTL) confirmed that peptide-binding CD8+T cells were present in pooled lymphocytes harvested from peptide-primed mice. These findings provide direct evidence for the existence of LV-derived GP epitopes that may be useful in the development of protective immunogens for this hemorrhagic virus.Keywords
This publication has 31 references indexed in Scilit:
- Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virusJournal of General Virology, 2004
- Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein–Barr virus helicase-primase-associated proteinJournal of Medical Virology, 2004
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicityMolecular Immunology, 1994
- MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motifInternational Immunology, 1993
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytesEuropean Journal of Immunology, 1993
- In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptidesEuropean Journal of Immunology, 1992
- A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy.BMJ, 1988
- Lassa FeverNew England Journal of Medicine, 1986